arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2302.13076physics.soc-phecon.GNq-fin.EC
收藏

创新中的秩序

Order in Innovation

Martin Ho, Henry CW Price, Tim S Evans, Eoin O'Sullivan

AI总结:

本研究结合复杂性科学与创新经济学,利用大规模疫苗数据集提出一种建立技术演进与复杂网络数学联系的方法,揭示了创新进展的秩序路径并量化了不同资助方的参与模式。

摘要:

日历时间是否是衡量创新的真实时钟?通过将复杂性科学与创新经济学相结合,并使用包含超过300万次引用和8项监管授权的疫苗数据集,我们发现日历时间和网络秩序以不同的准确度描述创新进展。首先,我们提出一种方法来建立技术演进与复杂网络之间的数学联系。其结果是一条叙述创新瓶颈的事件路径。接下来,我们量化文献相对于这些创新路径的位置与接近度,发现研究大体上从基础研究、应用研究、开发推进到商业化。进一步地,我们能够因果量化创新资助方的参与情况。在疫苗创新方面,扩散导向型实体专注于基础和后期研究;生物制药企业倾向于参与后期应用开发活动与临床试验;而任务导向型实体倾向于发起早期研究。未来的创新项目与资金分配将受益于对创新秩序的更好理解。

英文摘要:

Is calendar time the true clock of innovation? By combining complexity science with innovation economics and using vaccine datasets containing over three million citations and eight regulatory authorisations, we discover that calendar time and network order describe innovation progress at varying accuracy. First, we present a method to establish a mathematical link between technological evolution and complex networks. The result is a path of events that narrates innovation bottlenecks. Next, we quantify the position and proximity of documents to these innovation paths and find that research, by and large, proceed from basic research, applied research, development, to commercialisation. By extension, we are able to causally quantify the participation of innovation funders. When it comes to vaccine innovation, diffusion-oriented entities are preoccupied with basic, later-stage research; biopharmaceuticals tend to participate in applied development activities and clinical trials at the later-stage; while mission-oriented entities tend to initiate early-stage research. Future innovation programs and funding allocations would benefit from better understanding innovation orders.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑